Risk reduction for stroke and coronary events

Lancet. 2002 Apr 6;359(9313):1249-50; author reply 1250-1. doi: 10.1016/S0140-6736(02)08235-1.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Letter

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Antihypertensive Agents / therapeutic use*
  • Benzothiadiazines
  • Clinical Trials as Topic / methods*
  • Diuretics
  • Humans
  • Sodium Chloride Symporter Inhibitors / therapeutic use
  • Stroke / prevention & control*

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Benzothiadiazines
  • Diuretics
  • Sodium Chloride Symporter Inhibitors